Dementia Prevention: Methodological Explanations for Inconsistent Results
The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
The prevention of neurodegenerative dementias, such as Alzheimer disease, is a growing public health concern, because of a lack of effective curative treatment options and a rising global prevalence. Various potential risk or preventive factors have been suggested by epidemiologic research, including modifiable lifestyle factors, such as social contacts, leisure activities, physical exercise, and diet, as well as some preventive pharmacologic strategies, such as hormone replacement therapy, nonsteroidal antiinflammatory drugs, and Ginkgo biloba. Some factors have been targeted by interventions tested in randomized controlled trials, but many of the results are in conflict with observational evidence. The aim of this paper is to review the epidemiologic data linking potential protective factors to dementia or cognitive decline and to discuss the methodological limitations that could explain conflicting results. A thorough review of the literature suggests that, even if there are consistent findings from large observational studies regarding preventive or risk factors for dementia, few randomized controlled trials have been designed specifically to prove the protective effects of interventions based on such factors on dementia incidence. Because of the multifactorial origin of dementia, it appears that multidomain interventions could be a suitable candidate for preventive interventions, but designing such trials remains very challenging for researchers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Leisure Activities and the Risk of Dementia in the Elderly
Verghese, J., Lipton, R. B., Katz, M. J., Hall, C. B., Derby, C. A., Kuslansky, G., Ambrose, A. F., Sliwinski, M., & Buschke, H. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022252 · Cited by 1,961
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496 · cited 3×
“All trials found cognitive training to have some beneficial effects on cognition, especially in the cognitive domains directly related to the intervention, and these effects were found to last up to 5 years in this study, which also found some effects on everyday functioning (132).”
BackgroundInfluentialLarson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., Crane, P., & Kukull, W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00004 · Cited by 1,463
Forette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Influence of social network on occurrence of dementia: a community-based longitudinal study
Fratiglioni, L., Wang, H.-X., Ericsson, K., Maytan, M., & Winblad, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02113-9 · Cited by 1,361 · cited 1×
“Exposure definition and measurement vary greatly among studies (73): Some used quantitative measures of numbers of social contacts or activities (77, 94, 111, 117), while others attempted to gauge their frequency or intensity (78, 95, 97) or satisfaction with social interactions (80).”
BackgroundLindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 23×
“One study found that antihypertensive treatment was associated with a decreased risk of vascular dementia but not Alzheimer disease (249), while three found no association with dementia (104, 221, 250).”
BackgroundInfluentialDiabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Physical Activity, Including Walking, and Cognitive Function in Older Women
Weuve, J. (2004) · JAMA · doi:10.1001/jama.292.12.1454 · Cited by 1,175
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Mediterranean diet and risk for Alzheimer's disease
Scarmeas, N., Stern, Y., Tang, M., Mayeux, R., & Luchsinger, J. A. (2006) · Annals of Neurology · doi:10.1002/ana.20854 · Cited by 1,103
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease
Rovio, S., Kåreholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Nissinen, A., & Kivipelto, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70198-8 · Cited by 1,054 · cited 3×
“The window of exposure is important, even if the two longitudinal studies that assessed the effect of physical exercise in midlife report contradictory results (121, 122).”
BackgroundResultCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049 · cited 1×
“Two reviews (259, 260) studied the relation between diabetes and cognitive decline and concluded that, compared with people without diabetes, people with diabetes have a 1.”
BackgroundUse it or lose it: Engaged lifestyle as a buffer of cognitive decline in aging?
Hultsch, D. F., Hertzog, C., Small, B. J., & Dixon, R. A. (1999) · Psychology and Aging · doi:10.1037/0882-7974.14.2.245 · Cited by 1,023
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
Social Disengagement and Incident Cognitive Decline in Community-Dwelling Elderly Persons
Bassuk, S. S., Glass, T. A., & Berkman, L. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00002 · Cited by 991
A Prospective Study of Physical Activity and Cognitive Decline in Elderly Women: Women Who Walk
Yaffe, K., Barnes, D., Nevitt, M., Lui, L.-Y., & Covinsky, K. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.14.1703 · Cited by 921
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883 · cited 1×
“Eleven studies found midlife hypertension to be associated with an increased risk of dementia (122, 236–239) or cognitive decline (240–245) during late life, although the relation was sometimes restricted to a certain type of dementia (vascular dementia not Alzheimer disease) (122), either systolic or diastolic blood…”
BackgroundSeeman, T. E., Lusignolo, T. M., Albert, M., & Berkman, L. (2001) · Health Psychology · doi:10.1037/0278-6133.20.4.243 · Cited by 855 · cited 1×
“Two studies (90, 91) found only certain measures of social engagement to be associated with better cognitive function, and four studies found no association between participation in social activities (92, 93) or social network or support measures (91, 94) and cognition.”
BackgroundInfluence of leisure activity on the incidence of Alzheimer's disease
Scarmeas, N., Levy, G., Tang, M.-X., Manly, J., & Stern, Y. (2001) · Neurology · doi:10.1212/wnl.57.12.2236 · Cited by 831 · cited 3×
“Several studies simultaneously assessed the effects of different types of leisure activities on dementia or cognitive decline, often grouping them into categories of ‘‘social,’’ ‘‘physical,’’ or ‘‘intellectual’’ activities (77, 78, 87, 92, 93, 95, 99).”
BackgroundYoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
The Relation Between Everyday Activities and Successful Aging: A 6-Year Longitudinal Study
Menec, V. H. (2003) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/58.2.s74 · Cited by 825
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · cited 7×
“In nutritional intervention, the trial with the lowest attrition rate was the only trial able to demonstrate significant benefits of supplementation (63).”
BackgroundInfluentialWalking and Dementia in Physically Capable Elderly Men
Abbott, R. D. (2004) · JAMA · doi:10.1001/jama.292.12.1447 · Cited by 743
Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function
Kramer, A. F., & Erickson, K. I. (2007) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.06.009 · Cited by 741
Zunzunegui, M.-V., Alvarado, B. E., Del Ser, T., & Otero, A. (2003) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/58.2.s93 · Cited by 719
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717
Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700
Dietary patterns and risk of dementia: The Three-City cohort study
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J. F., & Alpérovitch, A. (2007) · Neurology · doi:10.1212/01.wnl.0000278116.37320.52 · Cited by 700
Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W. F., & Wolf, P. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1545 · Cited by 686 · cited 1×
“High plasma phosphatidylcholine docosahexaenoic acid was also associated with a lower risk of all-cause dementia, but not Alzheimer disease, in one study (52) and less cognitive decline in two other studies (53, 54).”
ResultMorris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · cited 13×
“Szekely CA, Breitner JC, Fitzpatrick AL, et al. NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type.”
BackgroundInfluentialPodewils, L. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi092 · Cited by 675
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Hypertension Is Related to Cognitive Impairment: A 20-Year Follow-up of 999 Men
Kilander, L., Nyman, H., Boberg, M., Hansson, L., & Lithell, H. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.780 · Cited by 630
A Longitudinal Study of Cardiorespiratory Fitness and Cognitive Function in Healthy Older Adults
Barnes, D. E., Yaffe, K., Satariano, W. A., & Tager, I. B. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51153.x · Cited by 608
Social resources and cognitive decline in a population of older African Americans and whites
Barnes, L. L., Mendes de Leon, C. F., Wilson, R. S., Bienias, J. L., & Evans, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000147473.04043.b3 · Cited by 572
Estrogen and cognitive functioning in women
Sherwin, B. B. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0016 · Cited by 560
Predictors of cognitive change in older persons: MacArthur studies of successful aging.
Albert, M. S., Jones, K., Savage, C. R., Berkman, L., Seeman, T., Blazer, D., & Rowe, J. W. (1995) · Psychology and Aging · doi:10.1037/0882-7974.10.4.578 · Cited by 543
Karp, A., Paillard-Borg, S., Wang, H.-X., Silverstein, M., Winblad, B., & Fratiglioni, L. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089919 · Cited by 542 · cited 2×
“Furthermore, two studies noted that the beneficial effects of cognitive, social, and physical activities on dementia (76) or cognitive decline (87) were greatest when older persons had high levels of participation in activities TABLE 2.”
BackgroundIs Diabetes Associated With Cognitive Impairment and Cognitive Decline Among Older Women?
Gregg, E. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.174 · Cited by 521
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498 · cited 1×
“A review of observational studies (177) concluded that long-term use of NSAIDs could significantly reduce the risk of dementia.”
BackgroundHaan, M. N. (1999) · JAMA · doi:10.1001/jama.282.1.40 · Cited by 457
Cognitive activity and incident AD in a population-based sample of older persons
Wilson, R. S., Bennett, D. A., Bienias, J. L., Aggarwal, N. T., Mendes de Leon, C. F., Morris, M. C., Schneider, J. A., & Evans, D. A. (2002) · Neurology · doi:10.1212/01.wnl.0000036905.59156.a1 · Cited by 456
Fish Consumption and Cognitive Decline With Age in a Large Community Study
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., & Wilson, R. S. (2005) · Archives of Neurology · doi:10.1001/archneur.62.12.noc50161 · Cited by 428
Social and Leisure Activities and Risk of Dementia: A Prospective Longitudinal Study
Fabrigoule, C., Letenneur, L., Dartigues, J. F., Zarrouk, M., Commenges, D., & Barberger‐Gateau, P. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb06093.x · Cited by 418
Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.203 · Cited by 414 · cited 1×
“Five studies found no association between vitamin E (37, 44, 45), vitamin C (22, 37, 44–46), flavonoids (44), or beta-carotene (22, 31, 44–46) and dementia/Alzheimer disease or cognitive decline.”
BackgroundRelation of cognitive activity to risk of developing Alzheimer disease
Wilson, R. S., Scherr, P. A., Schneider, J. A., Tang, Y., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271087.67782.cb · Cited by 400
Leisure activities and the risk of amnestic mild cognitive impairment in the elderly
Verghese, J., LeValley, A., Derby, C., Kuslansky, G., Katz, M., Hall, C., Buschke, H., & Lipton, R. B. (2006) · Neurology · doi:10.1212/01.wnl.0000202520.68987.48 · Cited by 373 · cited 3×
“Several studies simultaneously assessed the effects of different types of leisure activities on dementia or cognitive decline, often grouping them into categories of ‘‘social,’’ ‘‘physical,’’ or ‘‘intellectual’’ activities (77, 78, 87, 92, 93, 95, 99).”
BackgroundEstrogen use, APOE, and cognitive decline: Evidence of gene–environment interaction
Yaffe, K., Haan, M., Byers, A., Tangen, C., & Kuller, L. (2000) · Neurology · doi:10.1212/wnl.54.10.1949 · Cited by 371 · cited 1×
“Seven studies have suggested that current or previous estrogen use alone may be associated with a decreased risk of dementia (146–148) or cognitive decline (149, 150), although in some cases effects were limited to only some specific cognitive domains or to subjects with the APOE*E4 genotype (149, 151, 152).”
BackgroundNIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study
Elias, P. K., Elias, M. F., D'Agostino, R. B., Cupples, L. A., Wilson, P. W., Silbershatz, H., & Wolf, P. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1388 · Cited by 368
Hypertension and the Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Manly, J., Mayeux, R., & Luchsinger, J. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1734 · Cited by 360
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group (2007) · Neurology · doi:10.1212/01.wnl.0000260269.93245.d2 · Cited by 354 · cited 3×
“The Alzheimer Disease Antiinflammatory Prevention Trial Study (190) found an increased risk of dementia among subjects receiving NSAIDs, but few dementia events were observed in the shortened follow-up period, making it difficult to draw conclusions.”
BackgroundTucker, K. L., Qiao, N., Scott, T., Rosenberg, I., & Spiro, A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.627 · Cited by 351
van Gelder, B. M., Tijhuis, M., Kalmijn, S., & Kromhout, D. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.1142 · Cited by 346
Diet and risk of dementia: Does fat matter?: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2002) · Neurology · doi:10.1212/01.wnl.0000038345.77753.46 · Cited by 324
Allen, K. V., Frier, B. M., & Strachan, M. W. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.054 · Cited by 319
MacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313 · cited 1×
“However, one study (277) found no association between diabetes in midlife and risk of Alzheimer disease, and six studies (107, 270, 278, 282, 286, 287) found no association between diabetes in late life and risk of Alzheimer disease.”
BackgroundPhysical activity and Alzheimer's disease: from prevention to therapeutic perspectives
Rolland, Y., Abellan van Kan, G., & Vellas, B. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.02.007 · Cited by 312
Self-citationPhysical activity in relation to cognitive decline in elderly men: The FINE Study
van Gelder, B. M., Tijhuis, M. A. R., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2004) · Neurology · doi:10.1212/01.wnl.0000147474.29994.35 · Cited by 311
Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Wilson, R. S., Aggarwal, N. T., & Scherr, P. A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.508 · Cited by 302
Tervo, S., Kivipelto, M., Hänninen, T., Vanhanen, M., Hallikainen, M., Mannermaa, A., & Soininen, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076356 · Cited by 298
Fontbonne, A., Berr, C., Ducimetière, P., & Alpérovitch, A. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.366 · Cited by 297
Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study
Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Khachaturian, A. S., Bastian, L. A., Charoonruk, G., Tschanz, J. T., Norton, M. C., Pieper, C. F., Munger, R. G., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213814.43047.86 · Cited by 293 · cited 1×
“Fourteen studies found increased late-life blood pressure to be associated with increased dementia (107, 209– 212), mild cognitive impairment (213), or cognitive impairment/decline (83, 214–220), although in some cases the association was restricted to a certain age group (209), either systolic (209, 215, 220) or dias…”
BackgroundKado, D. M., Karlamangla, A. S., Huang, M.-H., Troen, A., Rowe, J. W., Selhub, J., & Seeman, T. E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.08.019 · Cited by 268
Does active leisure protect cognition? Evidence from a national birth cohort.
Richards, M., Hardy, R., & Wadsworth, M. E. J. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(02)00075-8 · Cited by 264 · cited 2×
“Five studies found that high levels of leisure activities decreased the risk of dementia (77) or cognitive function (94, 111, 123) or decline (124), and one study (117) found the individual activities of traveling, odd jobs, knitting, and gardening to be associated with a reduced risk of dementia.”
BackgroundKanaya, A. M., Barrett-Connor, E., Gildengorin, G., & Yaffe, K. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1327 · Cited by 255
Yamada, M., Kasagi, F., Sasaki, H., Masunari, N., Mimori, Y., & Suzuki, G. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51117.x · Cited by 255
Antihypertensive drugs and incidence of dementia: the Rotterdam Study
in’t Veld, B. A., Ruitenberg, A., Hofman, A., Stricker, B. H. C., & Breteler, M. M. B. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00241-4 · Cited by 254 · cited 1×
“One study found that antihypertensive treatment was associated with a decreased risk of vascular dementia but not Alzheimer disease (249), while three found no association with dementia (104, 221, 250).”
BackgroundBeydoun, M. A., Kaufman, J. S., Satia, J. A., Rosamond, W., & Folsom, A. R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.1103 · Cited by 253
Hassing, L. B. (2004) · Age and Ageing · doi:10.1093/ageing/afh100 · Cited by 249
Trajectories of Cognitive Decline and Social Relations
Béland, F., Zunzunegui, M.-V., Alvarado, B., Otero, A., & del Ser, T. (2005) · The Journals of Gerontology: Series B · doi:10.1093/geronb/60.6.p320 · Cited by 238
Kalmijn, S., Launer, L. J., Lindemans, J., Bots, M. L., Hofman, A., & Breteler, M. M. B. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010000 · Cited by 237
Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231 · cited 1×
“Five studies found no association between vitamin E (37, 44, 45), vitamin C (22, 37, 44–46), flavonoids (44), or beta-carotene (22, 31, 44–46) and dementia/Alzheimer disease or cognitive decline.”
BackgroundMorris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., & Evans, D. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1640 · Cited by 217
High-dose antioxidant supplements and cognitive function in community-dwelling elderly women
Grodstein, F., Chen, J., & Willett, W. C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.4.975 · Cited by 214
Transfer of a Speed of Processing Intervention to Near and Far Cognitive Functions
Edwards, J. D., Wadley, V. G., Myers, R. S., Roenker, D. L., Cissell, G. M., & Ball, K. K. (2002) · Gerontology · doi:10.1159/000065259 · Cited by 208
NSAID use and dementia risk in the Cardiovascular Health Study*: Role of APOE and NSAID type
Szekely, C. A., Breitner, J. C. S., Fitzpatrick, A. L., Rea, T. D., Psaty, B. M., Kuller, L. H., & Zandi, P. P. (2008) · Neurology · doi:10.1212/01.wnl.0000284596.95156.48 · Cited by 204
Low vitamin B-12 status and risk of cognitive decline in older adults
Clarke, R., Birks, J., Nexo, E., Ueland, P. M., Schneede, J., Scott, J., Molloy, A., & Evans, J. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1384 · Cited by 203
Exercise Level and Cognitive Decline: The MoVIES Project
Lytle, M. E., Vander Bilt, J., Pandav, R. S., Dodge, H. H., & Ganguli, M. (2004) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000126614.87955.79 · Cited by 200
Applegate, W. B. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420190047006 · Cited by 193
Di Bari, M., Pahor, M., Franse, L. V., Shorr, R. I., Wan, J. Y., Ferrucci, L., Somes, G. W., & Applegate, W. B. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.1.72 · Cited by 193
Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years
Logroscino, G., Kang, J. H., & Grodstein, F. (2004) · BMJ · doi:10.1136/bmj.37977.495729.ee · Cited by 190
Marital status and risk of Alzheimer’s disease: A French population-based cohort study
Helmer, C., Damon, D., Letenneur, L., Fabrigoule, C., Barberger-Gateau, P., Lafont, S., Fuhrer, R., Antonucci, T., Commenges, D., Orgogozo, J. M., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.1953 · Cited by 184
Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension
Peila, R., White, L. R., Masaki, K., Petrovitch, H., & Launer, L. J. (2006) · Stroke · doi:10.1161/01.str.0000217653.01615.93 · Cited by 181 · cited 1×
“Three studies found use or increased duration of use of antihypertensive treatment to be associated with a decreased dementia/Alzheimer disease risk (228, 247, 248).”
BackgroundDeKosky, S. T., Fitzpatrick, A., Ives, D. G., Saxton, J., Williamson, J., Lopez, O. L., Burke, G., Fried, L., Kuller, L. H., Robbins, J., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.02.007 · Cited by 176 · cited 1×
“The results of two large ongoing prevention trials (203, 204) will provide important data.”
BackgroundBickel, H., & Cooper, B. (1994) · Psychological Medicine · doi:10.1017/s0033291700026945 · Cited by 172
Plasma homocysteine levels and risk of Alzheimer disease
Luchsinger, J. A., Tang, M. X., Shea, S., Miller, J., Green, R., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000129504.60409.88 · Cited by 171
Broe, G. A., Creasey, H., Jorm, A. F., Bennett, H. P., Casey, B., Waite, L. M., Grayson, D. A., & Cullen, J. (1998) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1998.tb01449.x · Cited by 169
Mooijaart, S. P., Gussekloo, J., Frölich, M., Jolles, J., Stott, D. J., Westendorp, R. G., & de Craen, A. J. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.4.866 · Cited by 159
Women Who Maintain Optimal Cognitive Function into Old Age
Barnes, D. E., Cauley, J. A., Lui, L., Fink, H. A., McCulloch, C., Stone, K. L., & Yaffe, K. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01040.x · Cited by 145
Bosma, H., van Boxtel, M. P. J., Ponds, R. W. H. M., Jelicic, M., Houx, P., Metsemakers, J., & Jolles, J. (2002) · Zeitschrift f�r Gerontologie und Geriatrie · doi:10.1007/s00391-002-0080-y · Cited by 127 · cited 5×
“No studies were identified that failed to find an association between cognitive activities and outcomes, although the positive effects in one of the above-mentioned studies (87) were seen only in some specific cognitive domains.”
BackgroundResultInfluentialCalcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging
Yasar, S., Corrada, M., Brookmeyer, R., & Kawas, C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.009 · Cited by 116
Supplemental Use of Antioxidant Vitamins and Subsequent Risk of Cognitive Decline and Dementia
Maxwell, C. J., Hicks, M. S., Hogan, D. B., Basran, J., & Ebly, E. M. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000085074 · Cited by 105
Low dose aspirin and cognitive function in the women's health study cognitive cohort
Kang, J. H., Cook, N., Manson, J., Buring, J. E., & Grodstein, F. (2007) · BMJ · doi:10.1136/bmj.39166.597836.be · Cited by 103 · cited 2×
“The WHS cognitive cohort (191) involved 6,377 women aged over 65 years who were treated with low-dose aspirin or placebo for 9.”
BackgroundMethodIndividual differences in trajectory of intellectual development over 45 years of adulthood.
Arbuckle, T. Y., Maag, U., Pushkar, D., & Chaikelson, J. S. (1998) · Psychology and Aging · doi:10.1037/0882-7974.13.4.663 · Cited by 97
Birns, J., Morris, R., Donaldson, N., & Kalra, L. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000244934.81180.16 · Cited by 96 · cited 1×
“Two other metaanalyses (207, 208) with much less stringent inclusion/exclusion criteria noted modest or borderline protective effects of antihypertensive treatment on dementia or certain cognitive domains.”
Is antioxidant use protective of cognitive function in the community-dwelling elderly?
Gray, S. L., Hanlon, J. T., Landerman, L. R., Artz, M., Schmader, K. E., & Fillenbaum, G. G. (2003) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(03)80011-9 · Cited by 70
Wu, J. H., Haan, M. N., Liang, J., Ghosh, D., Gonzalez, H. M., & Herman, W. H. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(02)00464-7 · Cited by 68
Plasma carotenoids and tocopherols and cognitive function: A prospective study
Kang, J. H., & Grodstein, F. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.006 · Cited by 52
Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population.
Stewart, R., Prince, M., & Mann, A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51504.x · Cited by 45
Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
Khachaturian, A. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.noc60013 · Cited by 3 · cited 1×
“Three studies found use or increased duration of use of antihypertensive treatment to be associated with a decreased dementia/Alzheimer disease risk (228, 247, 248).”
Background
Cited by
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Self-citationHearing Loss and Incident Dementia
Lin, F. R., Metter, E. J., O’Brien, R. J., Resnick, S. M., Zonderman, A. B., & Ferrucci, L. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.362 · Cited by 1,539
Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial
Martínez-Lapiscina, E. H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvadó, J., San Julián, B., Sanchez-Tainta, A., Ros, E., Valls-Pedret, C., & Martinez-Gonzalez, M. Á. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304792 · Cited by 747
Kelly, M. E., Loughrey, D., Lawlor, B. A., Robertson, I. H., Walsh, C., & Brennan, S. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.02.004 · Cited by 509
“Interventions comprising modifiable lifestyle factors, such as cognitive, social, and physical activity, that may reduce the risk of cognitive decline have been gaining increasing interest (Coley et al., 2008; Mangialasche et al., 2012).”
Yu, J.-T., Xu, W., Tan, C.-C., Andrieu, S., Suckling, J., Evangelou, E., Pan, A., Zhang, C., Jia, J., Feng, L., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321913 · Cited by 482
Self-citation
Metadata
- Authors
- Coley, N., Andrieu, S., Gardette, V., Gillette-Guyonnet, S., Sanz, C., Vellas, B., & Grand, A.
- Venue
- Epidemiologic Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-14
- Volume
- 30
- Issue
- 1
- Pages
- 35-66
- ISSN
- 0193-936X (ISSN-L)
- 1478-6729
- OpenAlex
- W2155537822
- Cited by
- 154
- References
- 112
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.